Inicio › Enfermedad de Alzheimer › Ohio
Ensayos clínicos de Enfermedad de Alzheimer en Ohio
17 estudios sobre Enfermedad de Alzheimer buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2617, Blue Ash
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Local Institution - 1265, Cleveland
- Ohio State University, Columbus
- Local Institution - 1258, Dayton
- y 1 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Ohio State University, Columbus
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- NDx Clinical Research, Dayton
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Velocity Clinical Research - Blue Ash, Blue Ash
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Cleveland Clinic, Cleveland
- Local Institution - 0087, Columbus
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Insight Clinical Trials ( Site 1011), Independence
- Neuro-Behavioral Clinical Research ( Site 1028), North Canton
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Ohio State University, Columbus
- NDx Clinical Research Inc., Dayton
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- NDx Clinical Research, Inc., Dayton
- Care Access - Lima, Lima
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 0029, Cleveland
- Insight Clinical Trials LLC - Independence, Independence
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 jun 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- The Ohio State University, Columbus
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 jun 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Insight Clinical Trials LLC, Beachwood
- Valley Medical Research, Centerville
ReclutandoFase 3
Edades de 50 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Case Western Reserve University, Beachwood
- University of Cincinnati, Cincinnati
ReclutandoEstudio observacional
Edades de 25 a 55 · Todos los sexos · Actualizado el 18 may 2026 · NCT04165109Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Ohio University, Athens
- The Ohio State University, Columbus
Reclutando
Edades de 60 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT05748613Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- The Ohio State University, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 mar 2025 · NCT03019757De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.